These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 26088453)
1. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer? Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of HER2 mRNA expression by RNA in situ hybridization in canine mammary gland tumors: Comparison with immunohistochemistry analysis. Seung BJ; Cho SH; Kim SH; Lim HY; Sur JH PLoS One; 2020; 15(2):e0229031. PubMed ID: 32059046 [TBL] [Abstract][Full Text] [Related]
3. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889 [TBL] [Abstract][Full Text] [Related]
4. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study. Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867 [TBL] [Abstract][Full Text] [Related]
5. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231 [TBL] [Abstract][Full Text] [Related]
6. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas. Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107 [TBL] [Abstract][Full Text] [Related]
7. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215 [TBL] [Abstract][Full Text] [Related]
8. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer. Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060 [TBL] [Abstract][Full Text] [Related]
10. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study. Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer. Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096 [TBL] [Abstract][Full Text] [Related]
12. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas. Klopfleisch R; Lenze D; Hummel M; Gruber AD Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801 [TBL] [Abstract][Full Text] [Related]
13. HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland. Damasceno KA; Ferreira E; Estrela-Lima A; Gamba Cde O; Miranda FF; Alves MR; Rocha RM; de Barros AL; Cassali GD PLoS One; 2016; 11(8):e0160419. PubMed ID: 27490467 [TBL] [Abstract][Full Text] [Related]
14. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples. Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560 [TBL] [Abstract][Full Text] [Related]
15. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines. Ahern TE; Bird RC; Bird AE; Wolfe LG Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884 [TBL] [Abstract][Full Text] [Related]
17. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. Klopfleisch R; Lenze D; Hummel M; Gruber AD BMC Cancer; 2010 Nov; 10():618. PubMed ID: 21062462 [TBL] [Abstract][Full Text] [Related]
18. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295 [TBL] [Abstract][Full Text] [Related]
19. Over-expression of mammaglobin-B in canine mammary tumors. Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015 [TBL] [Abstract][Full Text] [Related]
20. Cross-species oncogenic signatures of breast cancer in canine mammary tumors. Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]